3 курс / Фармакология / Лекарственные_средства,_применяемые_в_акушерстве_и_гинекологии,
.pdfɁɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ⱥɦɩɢɰɢɥ- |
0,375–0,75 ɝ |
0,75–1,5 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɥɢɧ+ɫɭɥɶɛɚɤɬɚɦ («ɍɧɚ- |
|
|
|
|
|
|
|
ɡɢɧ», «ɋɭɥɚɰɢɥɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥ- |
0,375–0,625 ɝ |
0,75–1,25 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
|
|
|
ɫɥɨɬɚ («Ⱥɭɝɦɟɧɬɢɧ», |
|
|
|
|
|
|
|
«Ⱥɦɨɤɫɢɤɥɚɜ») |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,25 ɝ |
0,5–0,75 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɬɢɧ», «Ɂɢɧɧɚɬ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɢɬɪɨɮɭɪɚɧɬɨɢɧ («Ɏɭ- |
0,05–0,1 ɝ |
0,2–0,4 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
ɪɚɞɨɧɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɏɭɪɚɡɨɥɢɞɨɧ |
0,1 ɝ |
0,4 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɏɨɫɮɨɦɢɰɢɧ («Ɇɨɧɭ- |
3 ɝ |
3 ɝ |
ɜɧɭɬɪɶ |
1–2 ɫɭɬ |
|
|
|
ɪɚɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɥɢɞɢɤɫɨɜɚɹ ɤɢɫɥɨɬɚ |
0,5 ɝ |
2 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
(«ɇɟɜɢɝɪɚɦɨɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɢɩɟɦɢɞɨɜɚɹ ɤɢɫɥɨɬɚ |
0,4 ɝ |
0,8 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
(«ɉɚɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
152
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
ɨɫɧɨɜɧɨɣ |
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ɉɤɫɨɥɢɧɨɜɚɹ ɤɢɫɥɨɬɚ |
0,5 ɝ |
1–1,5 ɝ |
ɜɧɭɬɪɶ |
7–10 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɉɮɥɨɤɫɚɰɢɧ («Ɍɚɪɢ- |
0,1–0,2 ɝ |
0,2–0,4 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
ɇɚ ɩɟɪɢɨɞ ɥɟɱɟɧɢɹ |
|
|
ɜɢɞ») |
|
|
|
|
ɮɬɨɪɯɢɧɨɥɨɧɚɦɢ ɜɪɟ- |
|
|
ɢɥɢ |
|
|
|
|
ɦɟɧɧɨ ɩɪɟɤɪɚɳɚɸɬ |
|
|
ɉɟɮɥɨɤɫɚɰɢɧ («Ⱥɛɚɤ- |
0,2–0,4 ɝ |
0,4 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
ɝɪɭɞɧɨɟ ɜɫɤɚɪɦɥɢɜɚ- |
|
|
ɬɚɥ») |
|
|
|
|
ɧɢɟ |
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɐɢɩɪɨɮɥɨɤɫɚɰɢɧ |
0,25–0,5 ɝ |
0,5–0,75 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
(«Ʉɜɢɧɬɨɪ», «ɐɢɩɪɨ- |
|
|
|
|
|
|
|
ɛɚɣ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɨɦɟɮɥɨɤɫɚɰɢɧ («Ɇɚɤ- |
0,4 ɝ |
0,4–0,8 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
ɫɚɤɜɢɧ») |
|
|
|
|
|
ɊȺɋɌɂɌȿɅɖɇɕȿ ɍɊɈȺɇɌɂɋȿɉɌɂɄɂ
|
|
«Ʉɚɧɟɮɪɨɧ-ɇ» |
5 ɝ |
15 ɝ |
ɜɧɭɬɪɶ |
14–30 ɫɭɬ |
|
|
ɢɥɢ |
|
|
|
|
|
|
Ɏɢɬɨɥɢɡɢɧ |
5 ɝ |
15 ɝ |
ɜɧɭɬɪɶ |
14–30 ɫɭɬ |
|
|
ɢɥɢ |
|
|
|
|
|
|
Ɉɬɜɚɪ ɦɨɱɟɝɨɧɧɵɯ ɬɪɚɜ |
100 ɦɥ |
250–300 |
ɜɧɭɬɪɶ |
14–30 ɫɭɬ |
|
|
|
|
ɦɥ |
|
|
|
|
ȾȿɋȿɇɋɂȻɂɅɂɁɂɊɍɘɓȺə |
ɌȿɊȺɉɂə |
|
|
|
|
|
Ⱦɢɮɟɧɝɢɞɪɚɦɢɧ («Ⱦɢ- |
0,05 ɝ |
0,1 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
ɦɟɞɪɨɥ») |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
ɉɪɨɦɟɬɚɡɢɧ («Ⱦɢɩɪɚ- |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
|
|
153 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
|
154 |
|
|
|
|||||||
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
|
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
|
|
ɡɢɧ», «ɉɢɩɨɥɶɮɟɧ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɏɥɨɪɨɩɢɪɚɦɢɧ («ɋɭɩ- |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
ɪɚɫɬɢɧ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
Ɇɟɛɝɢɞɪɨɥɢɧ («Ⱦɢɚɡɨ- |
0,1 ɝ |
0,2–0,3 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
ɥɢɧ») |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
Ʉɟɬɨɬɢɮɟɧ |
0,001 ɝ |
0,002 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
ɏɢɮɟɧɚɞɢɧ («Ɏɟɧɤɚ- |
0,025 ɝ |
0,05– |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
ɪɨɥ») |
|
0,075 ɝ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
Ʌɨɪɚɬɚɞɢɧ («Ʉɥɚɪɢ- |
0,01 ɝ |
0,01 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ɉ85 ɉɨɫɥɟɪɨɞɨ- |
ȼɵɛɨɪ ɩɪɟɩɚɪɚɬɨɜ ɨɩɪɟɞɟ- |
|
|
|
|
Ɉɫɧɨɜɧɵɦɢ ɩɪɢɧɰɢ- |
|
|
|
ɜɨɣ ɫɟɩɫɢɫ |
ɥɹɟɬɫɹ ɜɨɡɛɭɞɢɬɟɥɟɦ ɢ ɬɹ- |
|
|
|
|
ɩɚɦɢ ɥɟɱɟɧɢɹ ɩɨɫɥɟ- |
|
|
|
Ɉ85 ɉɨɫɥɟɪɨɞɨ- |
ɠɟɫɬɶɸ ɩɪɨɰɟɫɫɚ. |
|
|
|
|
ɪɨɞɨɜɨɝɨ ɷɧɞɨɦɟɬɪɢɬɚ |
|
|
|
ɜɨɣ ɷɧɞɨɦɟɬɪɢɬ |
Ⱥ. ȺɇɌɂȻɂɈɌɂɄɂ |
|
|
|
|
ɹɜɥɹɸɬɫɹ ɪɚɰɢɨɧɚɥɶ- |
|
|
|
Ⱥɫɫɨɰɢɚɰɢɢ |
I. Ɇɨɧɨɬɟɪɚɩɢɹ |
|
|
|
|
ɧɚɹ ɚɧɬɢɛɚɤɬɟɪɢɚɥɶ- |
|
|
|
ɚɷɪɨɛɧɵɯ ɢ ɚɧɚ- |
|
|
1,2 ɝ |
3,6–4,8 ɝ |
ɜ/ɜ |
3–4 ɫɭɬ |
ɧɚɹ ɬɟɪɚɩɢɹ ɢ ɯɢɪɭɪ- |
|
|
|
Ⱥɦɨɤɫɢɰɢɥ- |
|
|
||||||
ɷɪɨɛɧɵɯ ɦɢɤɪɨ- |
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
ɝɢɱɟɫɤɚɹ ɫɚɧɚɰɢɹ ɩɨ- |
|
|
ɨɪɝɚɧɢɡɦɨɜ: |
|
ɫɥɨɬɚ («Ⱥɦɨɤɫɢɤɥɚɜ», |
|
|
|
|
ɥɨɫɬɢ ɦɚɬɤɢ (ɜɚɤɭɭɦ- |
|
Раздел |
E. сoli, Proteus |
|
«Ⱥɭɝɦɟɧɬɢɧ»), |
|
|
|
|
ɚɫɩɢɪɚɰɢɹ ɫɨɞɟɪɠɢ- |
|
|
|
|
|
|
|
|
|
|||
spp., Klebsiella |
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,375–0,625 ɝ |
1,125– |
ɜɧɭɬɪɶ |
4–5 ɫɭɬ |
ɦɨɝɨ ɦɚɬɤɢ; ɜɵɫɤɚɛ- |
|
|
spp., |
|
|
|
1,875 ɝ |
|
|
ɥɢɜɚɧɢɟ ɫɬɟɧɨɤ ɦɚɬɤɢ |
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
Enterobacter |
|
ɢɥɢ |
|
|
|
|
ɢ ɭɞɚɥɟɧɢɟ ɨɫɬɚɬɤɨɜ |
spp., |
|
Ɍɢɤɚɪɰɢɥ- |
3,1 ɝ |
12,4 ɝ |
ɜ/ɜ |
5–7 ɫɭɬ |
ɞɟɰɢɞɭɚɥɶɧɨɣ ɢɥɢ |
Enterococcus |
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
ɩɥɚɰɟɧɬɚɪɧɨɣ ɬɤɚɧɢ; |
spp., Bacteroides |
|
ɫɥɨɬɚ («Ɍɢɦɟɧɬɢɧ») |
|
|
|
|
ɩɪɨɦɵɜɧɨɟ ɞɪɟɧɢɪɨ- |
spp., |
|
ɢɥɢ |
|
|
|
|
ɜɚɧɢɟ ɦɚɬɤɢ ɚɧɬɢɫɟɩ- |
Peptostrepto- |
|
ɉɢɩɟɪɚɰɢɥɥɢɧ+ |
3 ɝ |
9 ɝ |
ɜ/ɜ |
5–7 ɫɭɬ |
ɬɢɱɟɫɤɢɦɢ ɪɚɫɬɜɨɪɚ- |
coccus spp., |
|
ɬɚɡɨɛɚɤɬɚɦ |
|
|
|
|
ɦɢ). |
ɫɬɪɟɩɬɨɤɨɤɤɢ |
|
ɢɥɢ |
|
|
|
|
ɉɪɢ ɷɧɞɨɦɟɬɪɢɬɟ |
ɝɪɭɩɩɵ ȼ., |
|
ɐɟɮɨɬɚɤɫɢɦ («Ʉɥɚɮɨ- |
1 ɝ |
3 ɝ |
ɜ/ɜ |
5–7 ɫɭɬ |
ɥɟɝɤɨɣ ɢ ɫɪɟɞɧɟɣ |
Staphylococcus |
|
ɪɚɧ», «Ɍɚɪɰɟɮɨɤɫɢɦ») |
|
|
|
|
ɫɬɟɩɟɧɢ ɬɹɠɟɫɬɢ |
spp., |
|
ɢɥɢ |
|
|
|
|
ɜɨɡɦɨɠɧɚ ɫɬɭɩɟɧɱɚɬɚɹ |
Сhlamidia |
|
ɐɟɮɨɩɟɪɚɡɨɧ («ɐɟɮɨ- |
1 ɝ |
1–2 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
ɚɧɬɢɛɚɤɬɟɪɢɚɥɶɧɚɹ |
trachomatis, |
|
ɛɢɞ») |
|
|
|
|
ɬɟɪɚɩɢɹ: ɜ ɬɟɱɟɧɢɟ |
Mycoplasma |
|
ɢɥɢ |
|
|
|
|
3–4 ɞɧɟɣ: |
hominis, |
|
ɐɟɮɬɚɡɢɞɢɦ («Ɏɨɪ- |
1 ɝ |
3 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
ɩɚɪɟɧɬɟɪɚɥɶɧɨɟ ɜɜɟ- |
Ureaplasma |
|
ɬɭɦ») |
|
|
|
|
ɞɟɧɢɟ ɩɪɟɩɚɪɚɬɨɜ, ɞɚ- |
urealyticum |
|
ɢɥɢ |
|
|
|
|
ɥɟɟ ɩɟɪɟɯɨɞ ɧɚ ɩɟɪɨ- |
ɢ ɞɪ. |
|
ɐɟɮɬɪɢɚɤɫɨɧ («Ɋɨɰɟ- |
1–2 ɝ |
1–2 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
ɪɚɥɶɧɵɟ ɮɨɪɦɵ ɷɬɢɯ |
|
|
ɮɢɧ», «ɐɟɮɬɪɢɚɛɨɥ») |
|
|
|
|
ɠɟ ɤɥɚɫɫɨɜ ɚɧɬɢɛɢɨ- |
|
|
|
|
|
|
|
ɬɢɤɨɜ |
|
Ʉɪɨɦɟ ɬɨɝɨ, ɩɪɢ ɬɹɠɟɥɨɣ ɮɨɪɦɟ ɷɧɞɨɦɟɬɪɢɬɚ: |
|
|
||||
|
|
ɐɟɮɨɩɟɪɚ- |
2 ɝ |
4–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɡɨɧ+ɫɭɥɶɛɚɤɬɚɦ |
|
|
|
|
|
|
|
(«ɋɭɥɶɩɟɪɚɡɨɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɂɦɢɩɟɧɟɦ+ɰɢɥɚɫɬɚɬɢɧ |
0,5–1 ɝ |
2–3 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
(«Ɍɢɟɧɚɦ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
155 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɪɨɩɟɧɟɦ («Ɇɟɪɨ- |
0,5–1 ɝ |
1,5–3 ɝ |
ɜ/ɜ |
5–7 ɫɭɬ |
|
|
|
ɧɟɦ») |
|
|
|
|
|
|
|
|
|
|
|
|
ɋɭɬɨɱɧɭɸ ɞɨɡɭ ɚɦɢ- |
|
ɢɥɢ |
|
|
|
|
|
|
|
II. Ʉɨɦɛɢɧɢɪɨɜɚɧɧɚɹ ɬɟɪɚ- |
|
|
|
|
ɧɨɝɥɢɤɨɡɢɞɨɜ ɰɟɥɟɫɨ- |
|
|
ɩɢɹ: |
|
|
|
|
ɨɛɪɚɡɧɨ ɜɜɨɞɢɬɶ ɜ 1–2 |
|
|
|
|
|
|
|
|
ɩɪɢɟɦɚ |
|
|
Ʉɥɢɧɞɚɦɢɰɢɧ |
0,3–0,9 ɝ |
0,9–2,7 ɝ |
ɜ/ɜ, ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6–1,2 ɝ |
1,2–2,4 ɝ |
ɜ/ɦ, ɜ/ɜ |
5–6 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɟɬɢɥɦɢɰɢɧ |
|
4–7,5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
3–4 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ («Ɏɥɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
3–4 ɫɭɬ |
|
|
|
ɝɢɥ», «ɗɮɥɨɪɚɧ», |
|
|
|
|
|
|
|
«Ʉɥɢɨɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,75–1,5 ɝ |
2,25–4,5 ɝ |
ɜ/ɜ, ɜ/ɦ |
3–4 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ȾȺɅȿȿ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
3–4 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
156
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ («Ɏɥɚ- |
0,5 ɝ |
1–2 ɝ |
ɜɧɭɬɪɶ |
3–4 ɫɭɬ |
|
|
|
ɝɢɥ», «ɗɮɥɨɪɚɧ», |
|
|
|
|
|
|
|
«Ʉɥɢɨɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,5 ɝ |
1 ɝ |
ɜɧɭɬɪɶ |
3–4 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6 ɝ |
1,8 ɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
ɐɟɮɭɪɨɤɫɢɦ («Ⱥɤɫɟ- |
0,75 ɝ |
2,25 ɝ |
ɜ/ɜ |
5–6 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
+ |
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ («Ɏɥɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɝɢɥ», «ɗɮɥɨɪɚɧ», |
|
|
|
|
|
|
|
«Ʉɥɢɨɧ») |
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,5 ɝ |
1–1,5 ɝ |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ʌɟɜɨɮɥɨɤɫɚɰɢɧ («Ɍɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɜɚɧɢɤ») |
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,25–0,5 ɝ |
0,5 ɝ |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
157 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ɉɮɥɨɤɫɚɰɢɧ («Ɍɚɪɢ- |
0,1–0,2 ɝ |
0,2–0,4 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɜɢɞ») |
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,2–0,4 ɝ |
0,4 ɝ |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɐɢɩɪɨɮɥɨɤɫɚɰɢɧ |
0,4–0,6 ɝ |
0,8–1,2 ɝ |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
(«Ʉɜɢɧɬɨɪ», «ɐɢɩɪɨ- |
|
|
|
|
|
|
|
ɛɚɣ», «ɐɢɩɪɨɥɟɬ») |
|
|
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
0,25–0,75 ɝ |
0,5–0,75 ɝ |
ɜɧɭɬɪɶ |
5–6 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ʉɥɢɧɞɚɦɢɰɢɧ |
0,3 ɝ |
0,9 ɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6 ɝ |
1,8 ɝ |
ɜ/ɦ |
5–6 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜɧɭɬɪɶ |
5–6 ɫɭɬ |
|
|
ɢɥɢ |
|
|
|
|
|
ɗɮɮɟɤɬɢɜɧɵ ɩɪɢ ɧɚ- |
|
|
|
|
|
|
|
ɥɢɱɢɢ ɯɥɚɦɢɞɢɨɡɚ, |
|
|
Ɋɨɤɫɢɬɪɨɦɢɰɢɧ («Ɋɭ- |
0,3 ɝ |
0,3 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɥɢɞ») |
|
|
|
|
ɦɢɤɨɩɥɚɡɦɨɡɚ ɢ ɭɪɟɚ- |
|
|
ɢɥɢ |
|
|
|
|
ɩɥɚɡɦɨɡɚ |
|
|
ɋɩɢɪɚɦɢɰɢɧ («Ɋɨɜɚɦɢ- |
1 500 000 ȿȾ |
4 500 000– |
ɜ/ɜ |
3 ɫɭɬ |
|
|
|
ɰɢɧ» |
|
6 000 000 |
|
|
|
|
|
|
|
ȿȾ |
|
|
|
|
|
ɡɚɬɟɦ ɜɧɭɬɪɶ |
1 500 000– |
4 500 000– |
ɜɧɭɬɪɶ |
3 ɫɭɬ |
|
|
|
ɢɥɢ |
3 000 000 ȿȾ |
6 000 000 |
|
|
|
|
|
|
|
ȿȾ |
|
|
|
|
|
Ⱦɠɨɡɚɦɢɰɢɧ («ȼɢɥɶɩ- |
0,5 ɝ |
1–1,5 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɪɨɮɟɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
158
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
ɉɊɈɎɂɅȺɄɌɂɄȺ ɄȺɇȾɂȾɈɁȺ |
|
|
|
|
||
|
|
Ɏɥɭɤɨɧɚɡɨɥ («Ⱦɢɮɥɸ- |
0,1 ɝ |
0,1 ɝ |
ɜ/ɜ |
1 ɪɚɡ ɜ 7 ɞɧɟɣ |
|
|
|
ɤɚɧ», «Ɏɥɸɤɨɫɬɚɬ») |
|
|
|
|
|
|
|
ɢ ɜɧɭɬɪɶ |
0,15 ɝ |
0,15 ɝ |
ɜɧɭɬɪɶ |
1 ɪɚɡ ɜ 7 ɞɧɟɣ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɢɫɬɚɬɢɧ |
500 000 ȿȾ |
2 000 000– |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
|
|
3 000 000 ȿȾ |
|
|
|
|
|
ȾȿɋȿɇɋɂȻɂɅɂɁɂɊɍɘɓȺə |
ɌȿɊȺɉɂə |
|
|
|
ɇɚɡɧɚɱɚɸɬ ɞɟɫɟɧɫɢ- |
|
|
Ⱦɢɮɟɧɝɢɞɪɚɦɢɧ («Ⱦɢ- |
1 ɦɥ |
2–3 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
ɛɢɥɢɡɢɪɭɸɳɢɟ Ʌɋ — |
|
|
ɦɟɞɪɨɥ») 1% ɪ-ɪ |
|
|
|
|
ɛɥɨɤɚɬɨɪɵ ɇ2- |
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,05 ɝ |
0,1 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
ɪɟɰɟɩɬɨɪɨɜ ɝɢɫɬɚɦɢɧɚ |
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɪɨɦɟɬɚɡɢɧ («Ⱦɢɩɪɚ- |
2,5% 2 ɦɥ |
4 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɡɢɧ», «ɉɢɩɨɥɶɮɟɧ») |
|
|
|
|
|
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɥɨɪɨɩɢɪɚɦɢɧ («ɋɭɩ- |
1 ɦɥ |
2 ɦɥ |
ɜ/ɦ |
5–7 ɫɭɬ |
|
|
|
ɪɚɫɬɢɧ») 2% ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ ɜɧɭɬɪɶ |
0,025 ɝ |
0,05 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɛɝɢɞɪɨɥɢɧ («Ⱦɢɚɡɨ- |
0,1 ɝ |
0,2–0,3 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɥɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʉɟɬɨɬɢɮɟɧ |
0,001 ɝ |
0,002 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɏɢɮɟɧɚɞɢɧ («Ɏɟɧɤɚ- |
0,025 ɝ |
0,05– |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
159 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɪɨɥ») |
|
0,075 ɝ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɨɪɚɬɚɞɢɧ («Ʉɥɚɪɢ- |
0,01 ɝ |
0,01 ɝ |
ɜɧɭɬɪɶ |
5–7 ɫɭɬ |
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɂɇɎɍɁɂɈɇɇȺə ɌȿɊȺɉɂə |
|
|
|
ɉɪɨɜɨɞɢɬɫɹ ɩɪɢ ɝɢ- |
||
|
|
Ⱦɟɤɫɬɪɨɡɚ 5% ɪ-ɪ (ɝɥɸ- |
400 ɦɥ |
400–800 |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3–4 ɫɭɬ |
ɩɟɪɬɟɪɦɢɢ ɢ ɢɧɬɨɤɫɢ- |
|
|
ɤɨɡɚ) |
|
ɦɥ |
|
|
ɤɚɰɢɢ. Ɉɛɳɢɣ ɨɛɴɟɦ |
|
|
ɢɥɢ |
|
|
|
|
ɢɧɮɭɡɢɨɧɧɨɣ ɬɟɪɚɩɢɢ |
|
|
ɏɥɨɪɢɞ ɧɚɬɪɢɹ |
400 ɦɥ |
400–800 |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3–4 ɫɭɬ |
1,2–1,5 ɥ/ɫɭɬ |
|
|
0,9% ɪ-ɪ |
|
ɦɥ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200–400 |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3–4 ɫɭɬ |
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨ- |
|
ɦɥ |
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɦɚɝɧɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨɤɚɪ- |
|
|
|
|
|
|
|
ɛɨɧɚɬ («Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
3–4 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
160
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
ɌȿɊȺɉɂə ɍɌȿɊɈɌɈɇɂɄȺɆɂ ɂ ɋɉȺɁɆɈɅɂɌɂɄȺɆɂ |
|
ɉɪɟɩɚɪɚɬɵ ɞɥɹ ɥɟɱɟ- |
||||
|
|
Ⱦɪɨɬɚɜɟɪɢɧɚ ɝɢɞɪɨɯɥɨ- |
2 ɦɥ |
4 ɦɥ |
ɜ/ɦ |
4–5 ɫɭɬ |
ɧɢɹ ɫɭɛɢɧɜɨɥɸɰɢɢ |
|
|
ɪɢɞ 2% ɪ-ɪ («ɇɨ-ɲɩɚ») |
|
|
|
|
ɦɚɬɤɢ; ɜɜɨɞɹɬɫɹ ɫ ɢɧ- |
|
|
|
|
|
|
|
ɬɟɪɜɚɥɨɦ 20–30 ɦɢɧ |
|
+ |
|
|
|
|
|
|
|
|
Ɉɤɫɢɬɨɰɢɧ |
5 ȿȾ |
10 ȿȾ |
ɜ/ɦ |
4–5 ɫɭɬ |
|
|
|
ɉɊɈɎɂɅȺɄɌɂɄȺ ɌɊɈɆȻɈɌɂɑȿɋɄɂɏ ɈɋɅɈɀɇȿɇɂɃ |
|
Ⱦɥɹ ɷɬɨɣ ɰɟɥɢ ɧɚɡɧɚ- |
|||
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
1–2 ɫɭɬ |
ɱɚɸɬ ɚɧɬɢɚɝɪɟɝɚɧɬɵ ɢ |
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
ɚɧɬɢɤɨɚɝɭɥɹɧɬɵ |
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5000 ȿȾ |
10 000– |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
|
|
15 000 ȿȾ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɚɥɬɟɩɚɪɢɧ ɧɚɬɪɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
(«Ɏɪɚɝɦɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɞɪɨɩɚɪɢɧ ɤɚɥɶɰɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
(«Ɏɪɚɤɫɢɩɚɪɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɗɧɨɤɫɚɩɚɪɢɧ ɧɚɬɪɢɹ |
0,2 ɦɥ |
0,2 ɦɥ |
ɩ/ɤ |
5 ɫɭɬ |
|
|
|
(«Ʉɥɟɤɫɚɧ») |
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ⱦɢɩɢɪɢɞɚɦɨɥ («Ʉɭɪɚɧ- |
0,025 ɝ |
0,075 ɝ |
ɜɧɭɬɪɶ |
5 ɫɭɬ |
|
|
|
ɬɢɥ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
161 ...заболеваний инфекционных терапии при применяемые ЛС,